The CDC released a statement claiming that “Antigen tests are an effective tool to help employers prevent the spread of COVID-19 in the workplace. Antigen tests, when used for screening employees in non-healthcare workplaces, can detect current infections before an employee enters the workplace or returns to work.”
As the exclusive commercialization partner and North American distributor of Access Bio’s CareStart™COVID-19 tests, Intrivo can provide healthcare and non-healthcare workplaces with the critical tools they need to help get their employees back to work safely.
Want to learn more about the difference between antigen testing and PCR? Check out our blog post here
Read the full CDC article here
The CareStart™ COVID-19 Antigen test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories and at the Point of Care by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.
The CareStartTM COVID-19 Antigen test is manufactured by Access Bio Inc. for Intrivo. CarestartTM is a trademark of Access Bio, Inc